CVS Group’s (CVSG) “Buy” Rating Reiterated at Berenberg Bank

CVS Group (LON:CVSG)‘s stock had its “buy” rating reissued by analysts at Berenberg Bank in a research report issued to clients and investors on Thursday, September 24th, MarketBeat Ratings reports. They currently have a GBX 2,000 price objective on the stock. Berenberg Bank’s price target indicates a potential upside of 74.37% from the stock’s previous close.

CVSG has been the subject of a number of other reports. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 1,700 price target on shares of CVS Group in a research report on Monday, July 27th. Jefferies Financial Group lifted their target price on shares of CVS Group from GBX 1,350 to GBX 1,400 and gave the company a “hold” rating in a research note on Friday, July 31st. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of GBX 1,666.67.

CVS Group Stock Down 5.9%

Shares of CVSG traded down GBX 72 during mid-day trading on Thursday, reaching GBX 1,147. The company’s stock had a trading volume of 341,284 shares, compared to its average volume of 877,581. The company has a market cap of £779.62 million, a price-to-earnings ratio of 16.65, a price-to-earnings-growth ratio of 1.77 and a beta of 1.07. The business has a fifty day moving average of GBX 1,283.30 and a 200 day moving average of GBX 1,228.61. The company has a quick ratio of 0.90, a current ratio of 1.18 and a debt-to-equity ratio of 110.41. CVS Group has a 1 year low of GBX 1,062 and a 1 year high of GBX 1,648.

CVS Group (LON:CVSG) last issued its quarterly earnings results on Thursday, September 24th. The company reported GBX 85.60 earnings per share for the quarter. CVS Group had a return on equity of 5.91% and a net margin of 2.43%. As a group, analysts forecast that CVS Group will post 93.9393939 earnings per share for the current fiscal year.

Insider Buying and Selling at CVS Group

In other CVS Group news, insider David Wilton purchased 1,500 shares of the business’s stock in a transaction dated Tuesday, August 4th. The shares were acquired at an average price of GBX 1,276 per share, for a total transaction of £19,140. Also, insider Robin Alfonso acquired 768 shares of the firm’s stock in a transaction that occurred on Thursday, August 6th. The stock was acquired at an average price of GBX 1,294 per share, with a total value of £9,937.92. Insiders acquired 3,860 shares of company stock worth $4,956,696 over the last ninety days. 1.48% of the stock is currently owned by insiders.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.